Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|42|4838-4872

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.42, 2018-01, pp. : 4838-4872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the unactivated conformations of protein kinases for small molecule drug discovery

By Alton Gordon R   Lunney Elizabeth A  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 595-605

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of Protein Kinases in Cancer- How to Overcome Resistance

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1101-1110

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Aurora Kinases Inhibitors

By  

Current Medicinal Chemistry, Vol. 16, Iss. 16, 2009-06 ,pp. : 1949-1963

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases

By Heiko van der Kuip  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition

By Backes AC   Zech B   Felber B   Klebl B   Müller G  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1409-1425

Informa Healthcare

Access to resources Recommend Favorite